Vpr localization within cell compartments does not change following vorinostat treatment.

Vpr localization within cell compartments does not change following vorinostat treatment.

<p>Western blot with indicated antibody on cell fractions from cells treated with DMSO or vorinostat. VOR = vorinostat. Sol nuc = soluble nuclear fraction.</p> <p>(TIF)</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Catherine A. Lewis (22177707) (author)
Diğer Yazarlar:	David M. Margolis (244046) (author), Edward P. Browne (8913893) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cell Biology Molecular Biology Biotechnology Immunology Developmental Biology Cancer Infectious Diseases Virology vorinostat potently enhances viral factors shape viral factors interact sup >+</ sup specific viral factors div >< p critical cellular factors 1 reporter strains 1 accessory proteins 1 accessory protein reservoir formation selects preventing reservoir formation regulate latency establishment 1 latency results 1 latency establishment prevents hiv transmission cure hiv infection vpr &# 8217 latent viral reservoir 1 protein vpr whether hdacs interact cell latency model host cell factors promoting hiv expression central memory cd4 latent reservoir central memory 1 entry vpr expression new latency cell subtypes cell death latent proviruses single hiv individual hiv allow hiv vpr possesses vpr plays significant increase recently shown promoting activity primary cd4 mediated restriction induced apoptosis histone deacetylases findings suggest dramatically improved clinical prognosis binding domain antiretroviral therapy
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Vpr p300-binding site and p300 acetyltransferrase activity required for combined effect of Vpr and vorinostat (VOR).
Yazar:: Catherine A. Lewis (22177707)
Baskı/Yayın Bilgisi: (2025)

Viral gene expression within productively infected (GFP<sup>+</sup>) cells is increased in the presence of Vpr and vorinostat (VOR).
Yazar:: Catherine A. Lewis (22177707)
Baskı/Yayın Bilgisi: (2025)

Vpr expression in functional mutant viruses.
Yazar:: Catherine A. Lewis (22177707)
Baskı/Yayın Bilgisi: (2025)

Induction of cell cycle arrest and apoptosis/cell death by Vpr.
Yazar:: Catherine A. Lewis (22177707)
Baskı/Yayın Bilgisi: (2025)

Model of role of Vpr in HIV-1 transcription and T-cell memory subset composition.
Yazar:: Catherine A. Lewis (22177707)
Baskı/Yayın Bilgisi: (2025)

Many more differentially expressed genes (DEGs) result from VOR treatment and Vpr expression than either condition alone.
Yazar:: Catherine A. Lewis (22177707)
Baskı/Yayın Bilgisi: (2025)

DEGs in HIV-GFP-Vpr- vs. HIV-GFP-infected cells within a previously published subset of cell death pathway-related genes [56].
Yazar:: Catherine A. Lewis (22177707)
Baskı/Yayın Bilgisi: (2025)

Vpr expression results in an increased fraction cells with T<sub>CM</sub>-like phenotype (CD45RA<sup>-</sup>CCR7<sup>+</sup>).
Yazar:: Catherine A. Lewis (22177707)
Baskı/Yayın Bilgisi: (2025)

Effect of single viral gene revertants on productive infection and viral gene expression.
Yazar:: Catherine A. Lewis (22177707)
Baskı/Yayın Bilgisi: (2025)

Memory subsets.
Yazar:: Catherine A. Lewis (22177707)
Baskı/Yayın Bilgisi: (2025)

The role of histone deacetylase inhibitors in latency prevention and reversal.
Yazar:: Catherine A. Lewis (22177707)
Baskı/Yayın Bilgisi: (2025)

HIV-GFP revertant viruses.
Yazar:: Catherine A. Lewis (22177707)
Baskı/Yayın Bilgisi: (2025)

Chemoproteomics Reveals FAM114A2 as a Functional Target of Wikstroelide E for Reversal of HIV‑1 Latency
Yazar:: Lianshuai Ding (19109516)
Baskı/Yayın Bilgisi: (2025)

The schematic diagram.
Yazar:: Xiaohui Deng (534130)
Baskı/Yayın Bilgisi: (2025)

Indisulam reactivates diverse HIV-1 proviruses.
Yazar:: Xiaohui Deng (534130)
Baskı/Yayın Bilgisi: (2025)

RBM39 participates in the establishment and maintenance of HIV-1 latency.
Yazar:: Xiaohui Deng (534130)
Baskı/Yayın Bilgisi: (2025)

RBM39 and YTHDC1 mediate Tat degradation via DDX5.
Yazar:: Xiaohui Deng (534130)
Baskı/Yayın Bilgisi: (2025)

RBM39 recruits YTHDC1 to promote Tat degradation.
Yazar:: Xiaohui Deng (534130)
Baskı/Yayın Bilgisi: (2025)

RBM39 mediates m⁶A methylation to regulate Tat mRNA stability.
Yazar:: Xiaohui Deng (534130)
Baskı/Yayın Bilgisi: (2025)

RBM39 is identified as a key host factor regulating Tat stability.
Yazar:: Xiaohui Deng (534130)
Baskı/Yayın Bilgisi: (2025)

Indisulam synergizes with other latency-reversing agents in reactivating HIV-1 latency.
Yazar:: Xiaohui Deng (534130)
Baskı/Yayın Bilgisi: (2025)

Effects of RBM39 knockdown and indisulam treatment on J-Lat cells.
Yazar:: Xiaohui Deng (534130)
Baskı/Yayın Bilgisi: (2025)

YTHDC1 facilitates Tat degradation.
Yazar:: Xiaohui Deng (534130)
Baskı/Yayın Bilgisi: (2025)

Matrix Regulation Data
Yazar:: Zihe Liu (15452695)
Baskı/Yayın Bilgisi: (2025)

CD24-Fc treatment increases CXCR5 + memory CD8 T cell and T cell functionality in PBMCs from PWH in vitro.
Yazar:: Guangming Li (607051)
Baskı/Yayın Bilgisi: (2025)

CD24-Fc treatment and HIV latency reversal delay HIV-1 rebound and reduce HIV pathogenesis after cART cessation.
Yazar:: Guangming Li (607051)
Baskı/Yayın Bilgisi: (2025)

CD24-Fc treatment leads to reduced HIV gene expression during cART and delayed HIV-1 rebound after cART cessation.
Yazar:: Guangming Li (607051)
Baskı/Yayın Bilgisi: (2025)

CD24-Fc treatment rescues CXCR5 + CD8 T cells and anti-HIV T cell response in vivo.
Yazar:: Guangming Li (607051)
Baskı/Yayın Bilgisi: (2025)

CD24-Fc improves human T cell recovery during HIV infection with cART.
Yazar:: Guangming Li (607051)
Baskı/Yayın Bilgisi: (2025)

CD24-Fc resolves inflammation during HIV infection with cART.
Yazar:: Guangming Li (607051)
Baskı/Yayın Bilgisi: (2025)

Related to Fig 6. CD24-Fc treatment rescues T cell function in PWH PBMCs in vitro.
Yazar:: Guangming Li (607051)
Baskı/Yayın Bilgisi: (2025)

Related to Fig 6. The functionality of CD8 T cells is impaired by HIV infection.
Yazar:: Guangming Li (607051)
Baskı/Yayın Bilgisi: (2025)

Related to Fig 5. Sustained CD24-Fc treatment after cART cessation and virus rebound rescues human immune cells.
Yazar:: Guangming Li (607051)
Baskı/Yayın Bilgisi: (2025)

Related to Fig 4. CD24-Fc treatment during cART does not rescue human immune cells after cART cessation and virus rebound.
Yazar:: Guangming Li (607051)
Baskı/Yayın Bilgisi: (2025)

Related to Fig 2. CD24-Fc treatment reduces HIV-1 pathogenesis during cART.
Yazar:: Guangming Li (607051)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 1_Unveiling altered CD8 T-cell metabolism and homeostatic proliferation behind a low CD4/CD8 ratio in ART-suppressed HIV individuals with normal CD4 recovery.docx
Yazar:: Vanesa Garrido-Rodríguez (14172573)
Baskı/Yayın Bilgisi: (2025)

Distribution of clones in the latent reservoir after early intervention.
Yazar:: Marco Garcia Noceda (22250847)
Baskı/Yayın Bilgisi: (2025)

Dynamics of the latent reservoir during ART.
Yazar:: Marco Garcia Noceda (22250847)
Baskı/Yayın Bilgisi: (2025)

Latent reservoir dynamics after ART initiation in 100 replicate simulations.
Yazar:: Marco Garcia Noceda (22250847)
Baskı/Yayın Bilgisi: (2025)

Distribution of clones in the HIV-1 latent reservoir early in infection.
Yazar:: Marco Garcia Noceda (22250847)
Baskı/Yayın Bilgisi: (2025)